← Back to headlines
Nuvation Receives Overweight Rating from J.P. Morgan
Nuvation has been upgraded to an Overweight rating by J.P. Morgan, citing the promising launch trajectory for its lead drug.
18 Aug, 16:06 — 18 Aug, 16:06
Sources
Showing 1 of 1 sources
